Section Arrow
ICLR.NASDAQ
- ICON plc
Quotes are at least 15-min delayed:2026/09/01 22:26 EDT
Regular Hours
Last
 161.4
-3.59 (-2.18%)
Day High 
165.355 
Prev. Close
164.99 
1-M High
180.885 
Volume 
604.61K 
Bid
114.88
Ask
164
Day Low
160.01 
Open
165.24 
1-M Low
150.855 
Market Cap 
12.73B 
Currency 美元 
P/E 253.83 
%Yield -- 
10-SMA 170.21 
20-SMA 167.35 
50-SMA 167.06 
52-W High 203.91 
52-W Low 66.57 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.65/11.12
Enterprise Value
15.72B
Balance Sheet
Book Value Per Share
121.55
Cash Flow
Cash Flow Yield
0.08
Income Statement
Total Revenue
8.25B
Operating Revenue Per Share
105.02
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BIAFbioAffinity Technologies Inc6.59+2.03+44.52%-- 
PSNLPersonalis17.06+0.28+1.67%-- 
DHRDanaher Corp206.93-6.63-3.10%38.07PE
RVTYRevvity126.59-2.08-1.62%61.86PE
OPKOPKO Health1.52+0.05+3.40%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.